Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival

NCT06431919 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Decompensated Cirrhosis
Cirrhotic Cardiomyopathy
Cirrhosis, Liver
Left Ventricular Diastolic Dysfunction
Acute Kidney Injury

Interventions

DRUG: Simvastatin 20mg
DRUG: Carvedilol 3.125 mg

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh

Collaborators

[object Object]